Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011 Sep 13. 7(10):584-94. [QxMD MEDLINE Link].
Del Brutto OH. Neurocysticercosis. Neurohospitalist. 2014 Oct. 4(4):205-12. [QxMD MEDLINE Link]. [Full Text].
Del Brutto OH. Neurocysticercosis. Handb Clin Neurol. 2014. 121:1445-59. [QxMD MEDLINE Link].
Roy B, Verma S, Awasthi R, Rathore RK, Venkatesan R, Yoganathan SA, et al. Correlation of phase values with CT Hounsfield and R2* values in calcified neurocysticercosis. J Magn Reson Imaging. 2011 Nov. 34(5):1060-4. [QxMD MEDLINE Link].
Saenz B, Ruiz-Garcia M, Jimenez E, Hernandez-Aguilar J, Suastegui R, Larralde C. Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults. Pediatr Infect Dis J. 2006 Sep. 25(9):801-3. [QxMD MEDLINE Link].
Shrestha B, Mainali P, Sayami S, Shrestha OK. Clinico-radiological Aspects of Neurocysticercosis in Pediatric Population in a Tertiary Hospital. JNMA J Nepal Med Assoc. 2013 Jul-Sep. 52(191):483-8. [QxMD MEDLINE Link].
Hernández RD, Durán BB, Lujambio PS. Magnetic resonance imaging in neurocysticercosis. Top Magn Reson Imaging. 2014 Jun. 23(3):191-8. [QxMD MEDLINE Link].
Das K, Mondal GP, Banerjee M, Mukherjee BB, Singh OP. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study. J Clin Neurosci. 2007 Dec. 14(12):1172-7. [QxMD MEDLINE Link].
Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg. 2003 Jul-Aug. 97(4):416-21. [QxMD MEDLINE Link].
Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med. 2006 Jul 4. 145(1):43-51. [QxMD MEDLINE Link].
Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004 Jan 15. 350(3):249-58. [QxMD MEDLINE Link].
Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008 Sep. 79(9):1050-5. [QxMD MEDLINE Link].
Caplan LR. How to manage patients with neurocysticercosis. Eur Neurol. 1997. 37(2):124. [QxMD MEDLINE Link].
Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. 2002 Dec. 2(12):751-62. [QxMD MEDLINE Link].
Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia. 1998 Oct. 39(10):1025-40. [QxMD MEDLINE Link].
Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology. 2002 Dec 10. 59(11):1730-4. [QxMD MEDLINE Link].
Carpio A, Hauser WA. Neurocysticercosis and epilepsy. Singh G, Prabhakar S, eds. Taenia Solium Cysticercosis. Oxon, UK: CABI Publishing; 2002. 211-20.
Carpio A, Placencia M, Santillan F. A proposal for classification of neurocysticercosis. Can J Neurol Sci. 1994 Feb. 21(1):43-7. [QxMD MEDLINE Link].
Carpio A, Santillan F, Leon P. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?. Arch Intern Med. 1995 Oct 9. 155(18):1982-8. [QxMD MEDLINE Link].
Correa D, Medina-Escutia, E. Host-parasite immune relationship in Taenia solium taeniosis and cysticercosis. Garcia HH, Martinez, SM eds. Taenia solium Taeniasis/Cysticercosis. 1999. 15-24.
Davis L. Neurocysticercosis and seizures: Avoiding the cost of antihelminthic treatment. Neurology. 2002. 59:1669-71.
Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow up of 450 cases. Med Res Council Special Reports. 1961. 299:1-58.
Escobar A. The pathology of neurocysticercosis. Cysticercosis of Central Nervous System. 1983:27-54.
Estanol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry. 1986 Oct. 49(10):1131-4. [QxMD MEDLINE Link].
Flisser A, Correa D, Evans CAW. Taenia solium cysticercosis: New revisited immunological aspects. Singh G, Prabhakar S, eds. Taenia Solium Cysticercosis. Oxon, UK: CABI Publish; 2002. 24-44.
Garcia HH, Martinez M, Gilman R. Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet. 1991 Aug 31. 338(8766):549-51. [QxMD MEDLINE Link].
Garg K, Singh K, Misra S. Single-enhancing lesions in Indians patients with seizures: a review. Epilepsy Res. 2002. 59:1730-1734.
Garg RK, Kar AM, Jain S. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis. J Assoc Physicians India. 1995 Oct. 43(10):706-7. [QxMD MEDLINE Link].
Goodman KA, Ballagh SA, Carpio A. Case-control study of seropositivity for cysticercosis in Cuenca, Ecuador. Am J Trop Med Hyg. 1999 Jan. 60(1):70-4. [QxMD MEDLINE Link].
Kramer LD. Medical treatment of cysticercosis--ineffective. Arch Neurol. 1995 Jan. 52(1):101-2. [QxMD MEDLINE Link].
Kramer LD, Locke GE, Byrd SE. Cerebral cysticercosis: documentation of natural history with CT [published erratum appears in Radiology 1989 Oct;173(1):286]. Radiology. 1989 May. 171(2):459-62. [QxMD MEDLINE Link].
Manreza ML. Neurocysticercosis in children. Trends in Pediatric Neurology. 1993. 295-8.
Martinez HR, Rangel-Guerra R, Arredondo-Estrada JH. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases. J Neurol Sci. 1995 May. 130(1):25-34. [QxMD MEDLINE Link].
McCormick GF, Zee CS, Heiden J. Cysticercosis cerebri. Review of 127 cases. Arch Neurol. 1982 Sep. 39(9):534-9. [QxMD MEDLINE Link].
Mitchell WG, Crawford TO. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics. 1988 Jul. 82(1):76-82. [QxMD MEDLINE Link].
Padma MV, Behari M, Misra NK. Albendazole in single CT ring lesions in epilepsy. Neurology. 1994 Jul. 44(7):1344-6. [QxMD MEDLINE Link].
Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry. 2000 Feb. 68(2):137-43. [QxMD MEDLINE Link].
Ramos-Kuri M, Montoya RM, Padilla A. Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol. 1992 Jun. 49(6):633-6. [QxMD MEDLINE Link].
Schantz PM. Cysticercosis in non-endemic countries: the example of United States. Teniasis/Cysticercosis por T. solium. 1996. 277-86.
Singhal BS, Salinas RA. Controversies in the Drug Treatment of Neurocysticercosis. Singh G, Prabhakar S, eds. Taenia Solium Cysticercosis. Oxon, UK: CABI Publish; 2002. 713-43.
Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNR Am J Neuroradiol. 1986 Mar-Apr. 7(2):235-42. [QxMD MEDLINE Link].
Teitelbaum GP, Otto RJ, Watanabe AT. MR imaging of neurocysticercosis. AJNR. 1989. 10:709-18.
Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989 Jan. 159(1):100-2. [QxMD MEDLINE Link].
White AC, Garcia HH. Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis. Curr Infect Dis Rep. 1999 Dec. 1(5):434-440. [QxMD MEDLINE Link].
Xiao ZX, Zhao CY, Liu YP. [Albendazole treatment in cerebral cysticercosis]. Chung Hua Nei Ko Tsa Chih. 1986 Feb. 25(2):100-2, 127. [QxMD MEDLINE Link].
Zee CS, Segall HD, Destian S. MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr. 1993 Nov-Dec. 17(6):932-9. [QxMD MEDLINE Link].